Header Logo

Connection

Rulin Hechter to Child

This is a "connection" page, showing publications Rulin Hechter has written about Child.
Connection Strength

0.471
  1. Quadrivalent Human Papillomavirus Vaccine Initiation in Boys Before and Since Routine Use: Southern California, 2009-2013. Am J Public Health. 2015 Dec; 105(12):2549-56.
    View in: PubMed
    Score: 0.079
  2. Secular trends in diagnostic code density in electronic healthcare data from health care systems in the Vaccine Safety Datalink project. Vaccine. 2013 Feb 04; 31(7):1080-5.
    View in: PubMed
    Score: 0.065
  3. Correlates for second-dose varicella vaccination in school-age children in a managed care organization in California. Pediatr Infect Dis J. 2012 Jul; 31(7):752-5.
    View in: PubMed
    Score: 0.063
  4. Second-dose varicella vaccination coverage in children and adolescents in a managed care organization in California, 2006-2009. Pediatr Infect Dis J. 2011 Aug; 30(8):705-7.
    View in: PubMed
    Score: 0.059
  5. Extended surveillance to assess safety of 9-valent human papillomavirus vaccine. Hum Vaccin Immunother. 2022 12 30; 18(7):2159215.
    View in: PubMed
    Score: 0.033
  6. Near Real-Time Surveillance to Assess the Safety of the 9-Valent Human Papillomavirus Vaccine. Pediatrics. 2019 12; 144(6).
    View in: PubMed
    Score: 0.026
  7. Safety of Quadrivalent Meningococcal Conjugate Vaccine in Children 2-10 Years. Pediatr Infect Dis J. 2017 Nov; 36(11):1087-1092.
    View in: PubMed
    Score: 0.023
  8. Human papillomavirus vaccine series completion in boys before and after recommendation for routine immunization. Vaccine. 2017 02 07; 35(6):897-902.
    View in: PubMed
    Score: 0.022
  9. Safety of Quadrivalent Meningococcal Conjugate Vaccine in 11- to 21-Year-Olds. Pediatrics. 2017 01; 139(1).
    View in: PubMed
    Score: 0.022
  10. Safety of Seasonal Influenza Vaccination in Hospitalized Surgical Patients: A Cohort Study. Ann Intern Med. 2016 05 03; 164(9):593-9.
    View in: PubMed
    Score: 0.020
  11. Vaccination and 30-Day Mortality Risk in Children, Adolescents, and Young Adults. Pediatrics. 2016 Mar; 137(3):e20152970.
    View in: PubMed
    Score: 0.020
  12. Unmasking in an observational vaccine safety study: Using type 2 diabetes mellitus as an example. Vaccine. 2015 Nov 17; 33(46):6224-6.
    View in: PubMed
    Score: 0.020
  13. Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases. JAMA Neurol. 2014 Dec; 71(12):1506-13.
    View in: PubMed
    Score: 0.019

© 2025 Kaiser Permanente